Free Trial

kneat.com Q4 2022 Earnings Report

kneat.com logo
C$5.93 +0.18 (+3.13%)
(As of 12/20/2024 05:17 PM ET)

kneat.com Earnings Headlines

We recommended Palantir in 2021, now we’re recommending this...
My research indicates there is only one investment that can meet AI's unprecedented demand for energy.
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
See More kneat.com Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like kneat.com? Sign up for Earnings360's daily newsletter to receive timely earnings updates on kneat.com and other key companies, straight to your email.

About kneat.com

kneat.com (TSE:KSI), together with its subsidiaries, designs, develops, and supplies software for data and document management within regulated environments in North America, Europe, and the Asia Pacific. The company offers the Kneat Gx platform, a configurable off-the-shelf application focused on validation lifecycle management and testing for biotechnology, pharmaceutical, and medical device manufacturing industries. Its platform is used in various applications, including document management, analytical instrument validation, method validation, commissioning and qualification, drawing management, utility and facility validation, cold chain validation, electronic logbook management, process validation, computer system validation, and cleaning validation. The company also provides professional services, including consulting, training, process mapping, project management, and other services. kneat.com, inc. is headquartered in Limerick, Ireland.

View kneat.com Profile

More Earnings Resources from MarketBeat

Upcoming Earnings